logo-loader
Small caps
Cann Global Ltd

Cann Global re-lists and starts afresh in medical marijuana space

Cann Global re-lists and starts afresh in medical marijuana space

Cann Global Ltd (ASX:CGB) managing director Sholom Feldman updates Proactive Investors on the company’s exciting transformation from a mining company into the medical cannabis space.

The company has recently been relisted on the Australian Stock Exchange and has raised revenue to help support the new focus, strategy and growth.

Impressive results are already being seen in the company’s hemp food division, medical research with a Israeli University and a joint venture with international health and wellness company Pharmacan.

Quick facts: Cann Global Ltd

Price: $0.03

Market: ASX
Market Cap: $65.69 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: hVIVO PLC's 2020 pipeline 'looking strong' as it expands...

hVIVO PLC's (LON:HVO) executive chairman Trevor Phillips tells Proactive London's Andrew Scott the business is now better positioned to be profitable next year. The creator of pioneering human disease models based upon viral challenge generated revenues of £5.9mln in the six months ended June...

7 hours, 25 minutes ago

2 min read